During the forecast period, the healthcare regulatory affairs outsourcing market is expected to develop at a CAGR of 11.3%. As of 2023, the market is worth $2 billion, and by 2033, it is predicted to be worth $5.8 billion. Drug and other medical equipment approval is a costly, time-consuming, and documentation-intensive procedure that puts companies under a lot of strain. Such circumstances are...